CapsoVision (CV) vs InMode (INMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CapsoVision (CV) has outperformed InMode (INMD) over the past year, gaining 38.9% versus a loss of 6.8%. InMode is the larger company by market cap ($806.2 million vs $348.0 million), about 2.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CV | INMD |
|---|---|---|
| Share price | $6.54 | $14.01 |
| Market cap | $348.00M | $806.19M |
| 1-day change | +0.62% | +0.14% |
| YTD return | -38.82% | -4.63% |
| 1-year return | +38.85% | -6.79% |
| 5-year return | — | -83.20% |
| P/E ratio (TTM) | — | 11.58 |
| Forward P/E | — | 10.21 |
| EPS (TTM) | $-0.45 | $1.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.37 | $16.74 |
| 52-week low | $4.38 | $12.72 |
| Distance from 52-week high | -57.45% | -16.31% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +45.26% | +15.42% |
| Average volume | 158.95K | 522.14K |
| Shares outstanding | 53.21M | 57.54M |
| Employees | 99 | 660 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- InMode is about 2.3 times larger than CapsoVision by market value ($806.19M vs $348.00M).
- CV has outperformed INMD by 45.6 percentage points over the past year.
About CapsoVision
CV stock →CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
Healthcare · Medical Devices · 99 employees
About InMode
INMD stock →InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Healthcare · Medical Devices · 660 employees
CV vs INMD FAQ
Which is bigger, CapsoVision or InMode?
InMode (INMD) is larger, with a market capitalization of $806.19M compared with $348.00M for CapsoVision (CV).
Which stock has performed better over the past year, CV or INMD?
CV returned +38.85% over the past 12 months, compared with -6.79% for INMD (price return, excluding dividends). Past performance does not predict future results.
Are CapsoVision and InMode in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.